Non-alcoholic fatty liver disease is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes.
暂无分享,去创建一个
Marco Dauriz | Enzo Bonora | Giacomo Zoppini | E. Bonora | C. Vassanelli | G. Zoppini | G. Targher | M. Dauriz | A. Mantovani | I. Pichiri | Giovanni Targher | Corrado Vassanelli | G. Morani | Isabella Pichiri | Alessandro Mantovani | Riccardo Rigolon | Giovanni Morani | R. Rigolon | Isabella Pichiri | Riccardo Rigolon
[1] D. Levy,et al. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. , 1994, JAMA.
[2] D. Levy,et al. Influence of blood pressure on left atrial size. The Framingham Heart Study. , 1995, Hypertension.
[3] L H Kuller,et al. Incidence of and risk factors for atrial fibrillation in older adults. , 1997, Circulation.
[4] D. Levy,et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. , 1998, Circulation.
[5] T. Gillebert,et al. Afterload induced changes in myocardial relaxation: a mechanism for diastolic dysfunction. , 1999, Cardiovascular research.
[6] Cynthia A. Carnes,et al. C-Reactive Protein Elevation in Patients With Atrial Arrhythmias: Inflammatory Mechanisms and Persistence of Atrial Fibrillation , 2001, Circulation.
[7] Bruce M Psaty,et al. Inflammation as a Risk Factor for Atrial Fibrillation , 2003, Circulation.
[8] Stephen S. Cha,et al. Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future Prevalence , 2006, Circulation.
[9] Tom Greene,et al. Assessing kidney function--measured and estimated glomerular filtration rate. , 2006, The New England journal of medicine.
[10] S. Goland,et al. Cardiac Abnormalities as a New Manifestation of Nonalcoholic Fatty Liver Disease: Echocardiographic and Tissue Doppler Imaging Assessment , 2006, Journal of clinical gastroenterology.
[11] G. Targher,et al. Prevalence of Nonalcoholic Fatty Liver Disease and Its Association With Cardiovascular Disease Among Type 2 Diabetic Patients , 2007, Diabetes Care.
[12] S. Kimmel,et al. Incidence and prevalence of abnormal liver associated enzymes in patients with atrial fibrillation in a routine clinical care population , 2008, Pharmacoepidemiology and drug safety.
[13] R. Bhopal,et al. Validity of electrocardiographic classification of left ventricular hypertrophy across adult ethnic groups with echocardiography as a standard. , 2008, Journal of electrocardiology.
[14] Jeroen J. Bax,et al. Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus. , 2008, Journal of the American College of Cardiology.
[15] M. Chonchol,et al. Nonalcoholic fatty liver disease as a contributor to hypercoagulation and thrombophilia in the metabolic syndrome. , 2009, Seminars in thrombosis and hemostasis.
[16] Udo Hoffmann,et al. Pericardial Fat, Intrathoracic Fat, and Measures of Left Ventricular Structure and Function: The Framingham Heart Study , 2009, Circulation.
[17] M. Ermani,et al. Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension. , 2009, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[18] K. Reinier,et al. Independent Contribution of Diabetes to Increased Prevalence and Incidence of Atrial Fibrillation , 2009, Diabetes Care.
[19] Udo Hoffmann,et al. Pericardial Fat Is Associated With Prevalent Atrial Fibrillation: The Framingham Heart Study , 2010, Circulation. Arrhythmia and electrophysiology.
[20] Chris Day,et al. A position statement on NAFLD/NASH based on the EASL 2009 special conference. , 2010, Journal of hepatology.
[21] R. D'Agostino,et al. Serum -Glutamyl Transferase and Risk of Heart Failure in the Community , 2010 .
[22] X. Jouven,et al. Mortality Associated With Atrial Fibrillation in Patients With Myocardial Infarction: A Systematic Review and Meta-Analysis , 2011, Circulation.
[23] Eung Ju Kim,et al. Total and Interatrial Epicardial Adipose Tissues Are Independently Associated With Left Atrial Remodeling in Patients With Atrial Fibrillation , 2011, Journal of cardiovascular electrophysiology.
[24] D. Harnois,et al. Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease , 2011 .
[25] Q. Anstee,et al. How big a problem is non-alcoholic fatty liver disease? , 2011, BMJ : British Medical Journal.
[26] Silvia G Priori,et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2011, Circulation.
[27] Eliseo Guallar,et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta‐analysis , 2011, Hepatology.
[28] Michael A Rosenberg,et al. Echocardiographic diastolic parameters and risk of atrial fibrillation: the Cardiovascular Health Study. , 2012, European heart journal.
[29] Shih‐Ann Chen,et al. Adipocytes modulate the electrophysiology of atrial myocytes: implications in obesity-induced atrial fibrillation , 2012, Basic Research in Cardiology.
[30] Enrico Barbieri,et al. Nonalcoholic Fatty Liver Disease Is Associated With Left Ventricular Diastolic Dysfunction in Patients With Type 2 Diabetes , 2012, Diabetes Care.
[31] G. Lip,et al. Inflammation in atrial fibrillation. , 2012, Journal of the American College of Cardiology.
[32] P. Whincup,et al. &ggr;-Glutamyltransferase, Hepatic Enzymes, and Risk of Incident Heart Failure in Older Men , 2012, Arteriosclerosis, thrombosis, and vascular biology.
[33] G. MacGowan,et al. Cardiac structure and function are altered in adults with non-alcoholic fatty liver disease. , 2012, Journal of hepatology.
[34] C. Byrne,et al. Diagnosis and Management of Nonalcoholic Fatty Liver Disease and Its Hemostatic/Thrombotic and Vascular Complications , 2013, Seminars in Thrombosis & Hemostasis.
[35] Christopher D Byrne,et al. Clinical Review: Nonalcoholic fatty liver disease: a novel cardiometabolic risk factor for type 2 diabetes and its complications. , 2013, The Journal of clinical endocrinology and metabolism.
[36] M. Rienstra,et al. Relation of circulating liver transaminase concentrations to risk of new-onset atrial fibrillation. , 2013, The American journal of cardiology.
[37] Rahul Wadke,et al. Atrial fibrillation. , 2022, Disease-a-month : DM.